What sector is PRTO in?

Healthcare, in the Biotechnology industry.

NYSE Arca · PRTOHealthcareBiotechnology

RCN Pareto Strategic Allocation ETF (PRTO)

$27.18−1.42%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$27.18▼ 2.16% in range

Sep 11, 2026Low $27.18 · High $27.91Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

RCN Pareto Strategic Allocation ETF closed at $27.18 on Sep 28, down 1.42%, within 0.0% of its lowest close since Sep 28. Volume of 112 shares was 0.31× its 20-day average (below normal).

Short interest was 623 shares at the Sep 15 settlement, up 205.4% from the prior report (3.2 days to cover).

Market cap—

Revenue · quarter$0.00—

Diluted EPS$-0.36—

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Sep 2827.18 – 27.91−2.6% from high

Volume1120.31× 20-day avg

Volatility · 60d—Annualised

Short % of float—3.2 days to cover

Net cash$142.5MCash $142.5M

Next earnings—Not scheduled

Split-adjusted performance

1W −2.2%1M —3M —6M —YTD —1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 139 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −3.9%, revenue growth +9.0%, net margin −231.7%, P/E 20.2×.

Short interest

Details →

Shares short623+205.4% vs prior

Days to cover3.2Settled Sep 15

% of float—

Short vol. 10d73.5%of daily volume

News about RCN Pareto Strategic Allocation ETF

All news →

No recent articles focused on RCN Pareto Strategic Allocation ETF. 1 articles mention it in passing.

Quick answers

What sector is PRTO in?: Healthcare, in the Biotechnology industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology